|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 January 2001, Vol. 97, No. 1, pp. 198-204
IMMUNOBIOLOGY
Synthesis and release of B-lymphocyte stimulator from
myeloid cells
Bernardetta Nardelli,
Ornella Belvedere,
Viktor Roschke,
Paul A. Moore,
Henrik S. Olsen,
Thi Sau Migone,
Svetlana Sosnovtseva,
Jeffrey A. Carrell,
Ping Feng,
Judith G. Giri, and
David M. Hilbert
From Human Genome Sciences, Inc, Rockville, MD.
B-lymphocyte stimulator (BLyS) is a recently identified novel
member of the tumor necrosis factor ligand superfamily shown to exist
in a membrane-bound and soluble form. BLyS was found to be specifically
expressed on cells of myeloid lineage and to selectively stimulate
B-lymphocyte proliferation and immunoglobulin production. The
expression of a cytokine involved in potentiation of humoral immune
responses, such as BLyS, is expected to be strictly controlled. The
goal of the present study was to examine regulation of BLyS levels in
monocytic cells in response to cytokines and during their
differentiation to macrophages and dendritic cells. The
presence of BLyS on the cell surface and in the culture medium of both
normal blood monocytes and on tumor cells of myelomonocytic origin was
demonstrated. BLyS gene expression and levels of
membrane-associated and soluble BLyS were found to be regulated by
cytokines, in particular interferon (IFN)- and to a lesser extent
interleukin-10 (IL-10). The expression of BLyS on monocyte membranes
was retained following differentiation into macrophages, but detection
on the surface of monocyte-derived dendritic cells required
stimulation with IFN- . Both IFN- and IL-10 enhanced the
release of soluble BLyS that was active in B-cell proliferation assays.
Cells transfected with BLyS complementary DNA mutated in a predicted
cleavage site failed to release BLyS into the culture medium, thereby
suggesting that soluble BLyS was derived from the membrane form. These
results provide further support for an important role for BLyS
expressed in myeloid cells in B-cell expansion and antibody responses.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Le Pottier, B. Bendaoud, Y. Renaudineau, P. Youinou, J.-O. Pers, and C. Daridon
New ELISA for B Cell-Activating Factor
Clin. Chem.,
October 1, 2009;
55(10):
1843 - 1851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Kim, J.-Y. Park, I. Jou, and S. M. Park
Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia
J. Leukoc. Biol.,
August 1, 2009;
86(2):
349 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tertilt, J. Joh, A. Krause, P. Chou, K. Schneeweiss, R. G. Crystal, and S. Worgall
Expression of B-Cell Activating Factor Enhances Protective Immunity of a Vaccine against Pseudomonas aeruginosa
Infect. Immun.,
July 1, 2009;
77(7):
3044 - 3055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Candon, J E Gottenberg, D Bengoufa, L Chatenoud, and X Mariette
Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren syndrome: correlation with B-cell biomarkers and disease activity
Ann Rheum Dis,
July 1, 2009;
68(7):
1208 - 1212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Di Carlo, T. D'Antuono, P. Pompa, R. Giuliani, S. Rosini, L. Stuppia, P. Musiani, and C. Sorrentino
The Lack of Epithelial Interleukin-7 and BAFF/BLyS Gene Expression in Prostate Cancer as a Possible Mechanism of Tumor Escape from Immunosurveillance
Clin. Cancer Res.,
May 1, 2009;
15(9):
2979 - 2987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sarantopoulos, K. E. Stevenson, H. T. Kim, C. S. Cutler, N. S. Bhuiya, M. Schowalter, V. T. Ho, E. P. Alyea, J. Koreth, B. R. Blazar, et al.
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
Blood,
April 16, 2009;
113(16):
3865 - 3874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D-A Landau, M Rosenzwajg, D Saadoun, D Klatzmann, and P Cacoub
The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders
Ann Rheum Dis,
March 1, 2009;
68(3):
337 - 344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ragheb, R. Lisak, R. Lewis, G. Van Stavern, F. Gonzales, and K. Simon
A Potential Role for B-Cell Activating Factor in the Pathogenesis of Autoimmune Myasthenia Gravis
Arch Neurol,
October 1, 2008;
65(10):
1358 - 1362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kanswal, N. Katsenelson, A. Selvapandiyan, R. J. Bram, and M. Akkoyunlu
Deficient TACI Expression on B Lymphocytes of Newborn Mice Leads to Defective Ig Secretion in Response to BAFF or APRIL
J. Immunol.,
July 15, 2008;
181(2):
976 - 990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Li, K. Su, C. Ji, A. J. Szalai, J. Wu, Y. Zhang, T. Zhou, R. P. Kimberly, and J. C. Edberg
Immune Opsonins Modulate BLyS/BAFF Release in a Receptor-Specific Fashion
J. Immunol.,
July 15, 2008;
181(2):
1012 - 1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Xu, P. A. Santini, A. J. Matthews, A. Chiu, A. Plebani, B. He, K. Chen, and A. Cerutti
Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF
J. Immunol.,
July 1, 2008;
181(1):
276 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Stohl, N. Jacob, W. J. Quinn III, M. P. Cancro, H. Gao, C. Putterman, X. Gao, L. Pricop, and M. N. Koss
Global T Cell Dysregulation in Non-Autoimmune-Prone Mice Promotes Rapid Development of BAFF-Independent, Systemic Lupus Erythematosus-Like Autoimmunity
J. Immunol.,
July 1, 2008;
181(1):
833 - 841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-A Kim, S.-H. Jeon, G.-Y. Seo, J.-B. Park, and P.-H. Kim
TGF-{beta}1 and IFN-{gamma} stimulate mouse macrophages to express BAFF via different signaling pathways
J. Leukoc. Biol.,
June 1, 2008;
83(6):
1431 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krumbholz, H. Faber, F. Steinmeyer, L.-A. Hoffmann, T. Kumpfel, H. Pellkofer, T. Derfuss, C. Ionescu, M. Starck, C. Hafner, et al.
Interferon-{beta} increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
Brain,
June 1, 2008;
131(6):
1455 - 1463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Chang, S. A. Mihalcik, and D. F. Jelinek
B Lymphocyte Stimulator Regulates Adaptive Immune Responses by Directly Promoting Dendritic Cell Maturation
J. Immunol.,
June 1, 2008;
180(11):
7394 - 7403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bossen, T. G. Cachero, A. Tardivel, K. Ingold, L. Willen, M. Dobles, M. L. Scott, A. Maquelin, E. Belnoue, C.-A. Siegrist, et al.
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts
Blood,
February 1, 2008;
111(3):
1004 - 1012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Woodland, C. J. Fox, M. R. Schmidt, P. S. Hammerman, J. T. Opferman, S. J. Korsmeyer, D. M. Hilbert, and C. B. Thompson
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival
Blood,
January 15, 2008;
111(2):
750 - 760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Jayasekera, C. G. Vinuesa, G. Karupiah, and N. J. C. King
Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice.
J. Gen. Virol.,
November 1, 2006;
87(Pt 11):
3361 - 3371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yoshimoto, Y. Takahashi, M. Ogasawara, Y. Setoyama, K. Suzuki, K. Tsuzaka, T. Abe, and T. Takeuchi
Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy
Int. Immunol.,
July 1, 2006;
18(7):
1189 - 1196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Halpern, P. Lappin, T. Zanardi, W. Cai, M. Corcoran, J. Zhong, and K. P. Baker
Chronic Administration of Belimumab, a BLyS Antagonist, Decreases Tissue and Peripheral Blood B-Lymphocyte Populations in Cynomolgus Monkeys: Pharmacokinetic, Pharmacodynamic, and Toxicologic Effects
Toxicol. Sci.,
June 1, 2006;
91(2):
586 - 599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bischof, S. F. Elsawa, G. Mantchev, J. Yoon, G. E. Michels, A. Nilson, S. L. Sutor, J. L. Platt, S. M. Ansell, G. von Bulow, et al.
Selective activation of TACI by syndecan-2
Blood,
April 15, 2006;
107(8):
3235 - 3242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. He, X. Qiao, P. J. Klasse, A. Chiu, A. Chadburn, D. M. Knowles, J. P. Moore, and A. Cerutti
HIV-1 Envelope Triggers Polyclonal Ig Class Switch Recombination through a CD40-Independent Mechanism Involving BAFF and C-Type Lectin Receptors
J. Immunol.,
April 1, 2006;
176(7):
3931 - 3941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. Elsawa, A. J. Novak, D. M. Grote, S. C. Ziesmer, T. E. Witzig, R. A. Kyle, S. R. Dillon, B. Harder, J. A. Gross, and S. M. Ansell
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia
Blood,
April 1, 2006;
107(7):
2882 - 2888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Novak, D. M. Grote, S. C. Ziesmer, M. P. Kline, M. K. Manske, S. Slager, T. E. Witzig, T. Shanafelt, T. G. Call, N. E. Kay, et al.
Elevated Serum B-Lymphocyte Stimulator Levels in Patients With Familial Lymphoproliferative Disorders
J. Clin. Oncol.,
February 20, 2006;
24(6):
983 - 987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Diaz-de-Durana, G. T. Mantchev, R. J. Bram, and A. Franco
TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo
Blood,
January 15, 2006;
107(2):
594 - 601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krumbholz, D. Theil, S. Cepok, B. Hemmer, P. Kivisakk, R. M. Ransohoff, M. Hofbauer, C. Farina, T. Derfuss, C. Hartle, et al.
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
Brain,
January 1, 2006;
129(1):
200 - 211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Butler, D. H. Francis, J. Freeling, P. Weber, and A. M. Krieg
Antibody Repertoire Development in Fetal and Neonatal Piglets. IX. Three Pathogen-Associated Molecular Patterns Act Synergistically to Allow Germfree Piglets to Respond to Type 2 Thymus-Independent and Thymus-Dependent Antigens
J. Immunol.,
November 15, 2005;
175(10):
6772 - 6785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zheng, S. Gallucci, J. P. Gaughan, J. A. Gross, and M. Monestier
A Role for B Cell-Activating Factor of the TNF Family in Chemically Induced Autoimmunity
J. Immunol.,
November 1, 2005;
175(9):
6163 - 6168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhang, K.-H. Ko, Q. L. K. Lam, C. K. C. Lo, G. Srivastava, B. Zheng, Y.-L. Lau, and L. Lu
Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis
Int. Immunol.,
August 1, 2005;
17(8):
1081 - 1092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Gavin, B. Duong, P. Skog, D. Ait-Azzouzene, D. R. Greaves, M. L. Scott, and D. Nemazee
{Delta}BAFF, a Splice Isoform of BAFF, Opposes Full-Length BAFF Activity In Vivo in Transgenic Mouse Models
J. Immunol.,
July 1, 2005;
175(1):
319 - 328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Schaller, W Stohl, S M Tan, V M Benoit, D M Hilbert, and H J Ditzel
Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis
Ann Rheum Dis,
May 1, 2005;
64(5):
743 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Ogden, J. D. Pound, B. K. Batth, S. Owens, I. Johannessen, K. Wood, and C. D. Gregory
Enhanced Apoptotic Cell Clearance Capacity and B Cell Survival Factor Production by IL-10-Activated Macrophages: Implications for Burkitt's Lymphoma
J. Immunol.,
March 1, 2005;
174(5):
3015 - 3023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krumbholz, D. Theil, T. Derfuss, A. Rosenwald, F. Schrader, C.-M. Monoranu, S. L. Kalled, D. M. Hess, B. Serafini, F. Aloisi, et al.
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
J. Exp. Med.,
January 18, 2005;
201(2):
195 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ohata, N. J. Zvaifler, M. Nishio, D. L. Boyle, S. L. Kalled, D. A. Carson, and T. J. Kipps
Fibroblast-Like Synoviocytes of Mesenchymal Origin Express Functional B Cell-Activating Factor of the TNF Family in Response to Proinflammatory Cytokines
J. Immunol.,
January 15, 2005;
174(2):
864 - 870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Scapini, A. Carletto, B. Nardelli, F. Calzetti, V. Roschke, F. Merigo, N. Tamassia, S. Pieropan, D. Biasi, A. Sbarbati, et al.
Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases
Blood,
January 15, 2005;
105(2):
830 - 837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Novak, D. M. Grote, M. Stenson, S. C. Ziesmer, T. E. Witzig, T. M. Habermann, B. Harder, K. M. Ristow, R. J. Bram, D. F. Jelinek, et al.
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome
Blood,
October 15, 2004;
104(8):
2247 - 2253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. He, X. Qiao, and A. Cerutti
CpG DNA Induces IgG Class Switch DNA Recombination by Activating Human B Cells through an Innate Pathway That Requires TLR9 and Cooperates with IL-10
J. Immunol.,
October 1, 2004;
173(7):
4479 - 4491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W Stohl, S Metyas, S-M Tan, G S Cheema, B Oamar, V Roschke, Y Wu, K P Baker, and D M Hilbert
Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus
Ann Rheum Dis,
September 1, 2004;
63(9):
1096 - 1103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Boule, C. Broughton, F. Mackay, S. Akira, A. Marshak-Rothstein, and I. R. Rifkin
Toll-like Receptor 9-Dependent and -Independent Dendritic Cell Activation by Chromatin-Immunoglobulin G Complexes
J. Exp. Med.,
June 21, 2004;
199(12):
1631 - 1640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W Stohl
A therapeutic role for BLyS antagonists
Lupus,
May 1, 2004;
13(5):
317 - 322.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Varfolomeev, F. Kischkel, F. Martin, D. Seshasayee, H. Wang, D. Lawrence, C. Olsson, L. Tom, S. Erickson, D. French, et al.
APRIL-Deficient Mice Have Normal Immune System Development
Mol. Cell. Biol.,
February 1, 2004;
24(3):
997 - 1006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Novak, J. R. Darce, B. K. Arendt, B. Harder, K. Henderson, W. Kindsvogel, J. A. Gross, P. R. Greipp, and D. F. Jelinek
Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival
Blood,
January 15, 2004;
103(2):
689 - 694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. O'Connor, V. S. Raman, L. D. Erickson, W. J. Cook, L. K. Weaver, C. Ahonen, L.-L. Lin, G. T. Mantchev, R. J. Bram, and R. J. Noelle
BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells
J. Exp. Med.,
January 5, 2004;
199(1):
91 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Schneider, S. Kothlow, P. Schneider, A. Tardivel, T. Gobel, B. Kaspers, and P. Staeheli
Chicken BAFF--a highly conserved cytokine that mediates B cell survival
Int. Immunol.,
January 1, 2004;
16(1):
139 - 148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. He, N. Raab-Traub, P. Casali, and A. Cerutti
EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching
J. Immunol.,
November 15, 2003;
171(10):
5215 - 5224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F Melchers
Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease
Ann Rheum Dis,
November 1, 2003;
62(90002):
ii25 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gorelik, K. Gilbride, M. Dobles, S. L. Kalled, D. Zandman, and M. L. Scott
Normal B Cell Homeostasis Requires B Cell Activation Factor Production by Radiation-resistant Cells
J. Exp. Med.,
September 15, 2003;
198(6):
937 - 945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Scapini, B. Nardelli, G. Nadali, F. Calzetti, G. Pizzolo, C. Montecucco, and M. A. Cassatella
G-CSF-stimulated Neutrophils Are a Prominent Source of Functional BLyS
J. Exp. Med.,
January 23, 2003;
(2003)
20021343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-G. Xu and H.-B. Shu
TNFR-Associated Factor-3 Is Associated With BAFF-R and Negatively Regulates BAFF-R-Mediated NF-{kappa}B Activation and IL-10 Production
J. Immunol.,
December 15, 2002;
169(12):
6883 - 6889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Park, D. Amichay, P. Love, E. Wick, F. Liao, A. Grinberg, R. L. Rabin, H. H. Zhang, S. Gebeyehu, T. M. Wright, et al.
The CXC Chemokine Murine Monokine Induced by IFN-{gamma} (CXC Chemokine Ligand 9) Is Made by APCs, Targets Lymphocytes Including Activated B Cells, and Supports Antibody Responses to a Bacterial Pathogen In Vivo
J. Immunol.,
August 1, 2002;
169(3):
1433 - 1443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Xu and K.-P. Lam
B-Cell Maturation Protein, Which Binds the Tumor Necrosis Factor Family Members BAFF and APRIL, Is Dispensable for Humoral Immune Responses
Mol. Cell. Biol.,
June 15, 2001;
21(12):
4067 - 4074.
[Abstract]
[Full Text]
|
 |
|
|
|